Poliklinika SLAVONIJA OSIJEK za opcu kirurgiju radiologiju baromedicinu ginekologiju i porodiljstvo i internu medicinu

The Poliklinika Slavonija Osijek team is advancing research aimed at reducing the risk of major adverse cardiovascular events in high‑risk patients, while also exploring new options for hypertension and atherosclerotic disease prevention.

• Primary prevention of ASCVD
• Hypertension management strategies
• Combination therapy for heart failure outcomes

With five active studies and three dedicated investigators, the site contributes valuable data to cardiovascular care across Europe.

Research at this clinic focuses on innovative treatments for type 2 diabetes, evaluating how new agents improve glycemic control and interact with existing therapies such as SGLT2 inhibitors.

• Glucose‑lowering drug efficacy
• Combination regimens with empagliflozin
• Impact on insulin resistance and metabolic markers

The investigations support the hospital’s commitment to advancing endocrine health for patients in Croatia and beyond.

The centre is conducting trials that target overweight and obesity, testing novel peptides and lifestyle‑enhanced interventions to achieve meaningful weight loss in adults with metabolic risk factors.

• Weekly peptide therapies for weight reduction
• Adjunct lifestyle counseling programs
• Body‑weight outcomes in participants with metabolic disease

These studies reflect a patient‑centered approach to managing metabolic disease at Poliklinika Slavonija Osijek.